Andrew Wu
Vancouver, BC V6T1Z4, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Identification of a PAK6-Mediated MDM2/p21 Axis That Modulates Survival and Cell Cycle Control of Drug-Resistant Stem/Progenitor Cells in Chronic Myeloid Leukemia.
Journal: International journal of molecular sciences
Published: June 06, 2025
Clinical Insights into Structure, Regulation, and Targeting of ABL Kinases in Human Leukemia.
Journal: International journal of molecular sciences
Published: February 21, 2024
Identification of multivariable microRNA and clinical biomarker panels to predict imatinib response in chronic myeloid leukemia at diagnosis.
Journal: Leukemia
Published: August 21, 2023
The Hedgehog Pathway as a Therapeutic Target in Chronic Myeloid Leukemia.
Journal: Pharmaceutics
Published: February 03, 2023
Multiple gene knockdown strategies for investigating the properties of human leukemia stem cells and exploring new therapies.
Journal: Methods in cell biology
Published: August 11, 2022
Identification of key microRNAs as predictive biomarkers of Nilotinib response in chronic myeloid leukemia: a sub-analysis of the ENESTxtnd clinical trial.
Journal: Leukemia
Published: June 29, 2022
p21-Activated kinases as promising therapeutic targets in hematological malignancies.
Journal: Leukemia
Published: August 18, 2021
In vitro assessment of anti-fibrotic drug activity does not predict in vivo efficacy in murine models of Duchenne muscular dystrophy.
Journal: Life sciences
Published: January 20, 2021
Showing 1-10 of 10
Last Updated: 09/26/2026